J’ONCO MENTOR

Desktop version. Mobile app coming.

Oncology Data Specialist Educational & Reference Utility — Version 9.09

ODS RESOURCES

Each major ODS resource now has its own section and navigation tab for direct access.

2027 standards cycle: J’Onco Mentor now links to the 2027 SEER Program Coding and Staging Manual, STORE 2027, Solid Tumor Rules 2027, the 2027 Hematopoietic Manual, NAACCR v27 implementation/edits resources, Summary Stage v3.4, and the current EOD v3.3 manual. Use diagnosis-year-specific instructions when standards differ by year.
Reference use: J’Onco Mentor is an educational utility. Verify final coding and staging decisions against the current governing source.

SEER*RSA / EOD

SUMMARY STAGE

SEER STAGING RESOURCES

SEER CODING MANUAL

SOLID TUMOR RULES

HEMATOPOIETIC & LYMPHOID DATABASE

STORE MANUAL

NCDB DATA SUBMISSION

NCDB / RCRS

NAACCR DATA DICTIONARY

NAACCR STANDARD DATA EDITS

REGISTRY-SPECIFIC EDITS

NAACCR IMPLEMENTATION GUIDELINES

NAACCR XML STANDARD

ICD-O-3

CAP PROTOCOLS

College of American Pathologists (CAP) Cancer Protocols support standardized pathology reporting. Use them to understand synoptic pathology findings; apply the governing registry manuals to determine final abstracted values.

CAP Protocols and Synoptic Reporting

CAP protocols organize pathology findings into structured data elements, including tumor site, histologic type, grade when applicable, tumor size or extent, margins, lymph node findings, and pathologic staging elements. The exact required elements depend on the applicable site-specific protocol and version.

What ODS Professionals Can Abstract

Use the synoptic report to locate documented primary site, histology, invasive extent, tumor size, grade, margins, lymphovascular invasion, number of regional nodes examined and involved, and reported pathologic TNM when available.

CAP vs. Registry Standards

CAP defines pathology reporting content. AJCC defines applicable TNM classifications; SEER, STORE, NAACCR, SSDI and other standard setters govern registry-specific data items, eligibility, coding rules and submission requirements. CAP findings do not automatically determine every registry field.

Common Site-Specific Protocols

Breast / Lung / Colon & Rectum

Review invasive extent, histologic type, grade as applicable, margins, regional lymph node findings and site-specific pathology elements.

Stomach / Prostate / Other Sites

Review tumor depth, treatment effect when applicable, regional nodes, grade and organ-specific protocol elements; use the current official CAP template for the case.

ODS Abstracting Examples

Synoptic findingHow it helpsRequired verification
Stomach resection: 5 of 18 regional nodes involvedSupports a positive-node count of 5 and a potential pN2 classification for an eligible gastric carcinoma.Confirm regional status, staging basis, diagnosis year, applicable AJCC chapter and any neoadjuvant treatment.
Colon resection: tumor invades muscularis propriaProvides evidence relevant to pathologic tumor extent.Apply the appropriate AJCC T definition and registry coding rules; review the complete report.
Breast synoptic report: margin status and invasive sizeProvides structured evidence for surgery and pathology abstraction.Check site-specific definitions, multiple foci, prior therapy and applicable registry fields.
Educational guidance: Use the protocol version appropriate to the procedure and report, and the registry standards appropriate to the diagnosis year. Do not substitute CAP synoptic fields for official registry coding instructions. Source: CAP Cancer Protocol Templates.

CANCER PATHCHART

SEER*RX DRUG LOOKUP

Use the dropdown to browse the loaded SEER*Rx catalog or type a generic, brand, or alternate drug name in the search box. On the hosted J’Onco Mentor site, the list is loaded from SEER*Rx through a server-side lookup and the selected drug record is retrieved from the official SEER*Rx page.

Start typing a drug name.
DRUG INFORMATION

Select or search for a drug

Category, subcategory, alternate names, abbreviations, primary-site context, remarks, and SEER*Rx coding guidance will appear here.

Important: The hosted lookup retrieves current SEER*Rx records. Always treat the official SEER*Rx record as the final authority, especially for historical changes and coding remarks.

SEER coding reminder: SEER states that drugs listed as chemotherapeutic, hormonal, or immunotherapy agents should be coded under the corresponding treatment data item regardless of the primary site shown for the agent. Verify the current SEER manual and SEER*Rx record for final coding.

GENERAL ODS TOOLS

J’Onco Mentor: Keep official source documentation one click away from the educational tools.
\n\n